期刊文献+

辛伐他汀对高胆固醇血症患者血脂及颈动脉粥样硬化的影响

Effects of simvastatin on serum lipid and carotid atherosclerosis of hypercholesteremia
下载PDF
导出
摘要 目的:观察辛伐他汀调脂作用及对颈动脉内膜中层厚度的影响。方法:选择高胆固醇血症或混合高脂血症患者189例,每日予以辛伐他汀10mg,酶法测定TC、TG、LDL-C、HDL-C,超声测定颈动脉内膜中层厚度。结果:每日予以辛伐他汀10mg能降低患者TC、TG、LDL-C,升高HDL-C,减缓颈动脉内膜中层增厚。结论:辛伐他汀能调节血脂,减缓颈动脉粥样硬化形成。 Objective To investigate the lipid-lowering efficacies of simvastatin and its effect on the intimamedia thickness(IMT) of the carotid artery.Methods 189 patients with hypercholesterolmia or combined hyperlipoproteinemia were studied,each one receiivins 10mg simvastatin once daily for 8 weeks.Carotid IMT and the serum concentration of TC、TG、LDL-C and HDL-C were measured at baseline and at the end of the treatment.Results At baseline the serum concentration of TC、TG、LDL-C and HDL-C were 4.75±1.40、2.58±1.30 、3.23±0.60 and 1.53±0.32mmol/L,respectively,Carotid IMT were 1.27±0.15mm;at the end of treatment the serum concentration of TC、TG、LDL-C decreased and HDL-C levels increased,Carotid IMT were 1.13±0.18mm.Conclusion Simvastatin has lipid-lowering efficacies and can suppress the development and progression of carotid atherosclerosis.
作者 魏新
出处 《安徽卫生职业技术学院学报》 2008年第3期86-87,共2页 Journal of Anhui Health Vocational & Technical College
关键词 辛伐他汀 高胆固醇血症 颈动脉 内膜中层厚度 Simvastatin Hypercholesterolmia intimamedia thickness(IMT) carotid artery
  • 相关文献

参考文献5

二级参考文献105

  • 1金立仁,陈万春,胡伟国,包玉倩.阿西莫司的降脂效应[J].新药与临床,1993,12(5):297-298. 被引量:7
  • 2陈斌,韩琴琴,陈曙霞,梅尚义,胡义桥,陈淑良.吉非贝齐与非诺贝特降脂疗效比较[J].新药与临床,1995,14(2):77-79. 被引量:12
  • 3王家良.循证医学(第1版)[M].北京:人民卫生出版社,2001.5-50. 被引量:3
  • 4中华心血管病杂志编辑委员会血脂异常防治对,中华心血管病杂志,1997年,25卷,169页 被引量:1
  • 5Yaughan C J,Lancet,1996年,348卷,1079页 被引量:1
  • 6David Moher, Kenneth F Schulz, Douglas G Altman, for the CONSORT Group. The CONSORT statement: revised recommendations for improving the quality of reports of paralleo-group randomized trials [J]. TheLancet, 2001; 357(4): 1 191-1 194 被引量:1
  • 7Stalenhoef AF, Lansberg PJ, Kroon AA, Kortmann B, De Haan AF,Stuyt PM, Kastelein JJ. Treatment of primary hypercholesterolaemia.Short-term efficacy and safety of increasing doses of simvastatin and pravastatin: a double-blind comparative study [ J ]. J Intem Med,1993; 234(1): 77-82 被引量:1
  • 8The European Study Group. Efficacy and tolerability of simvastatin and pravastatin in patients with primary hypercholesterolemia ( multicountry comparative study) [J ]. Am J Cardiol, 1992; 70 ( 15 ): 1281 - 1 286 被引量:1
  • 9Lambrecht LJ, Malini PL. Efficacy and tolerability of simvastatin 20mg vs pravastatin 20 mg in patients with primary hypercholesterolemia.European Study Group[J]. Acta Cardiol, 1993; 48(6): 541 -554 被引量:1
  • 10Steinhagen-Thiessen E. Comparative efficacy and tolerability of 5 and 10 mg simvastatin and 10 mg pravastatin in moderate primary hypercholesterolemia. Simvastatin Pravastatin European Study Group [J ].Cardiology, 1994; 85(3-4): 244-254 被引量:1

共引文献109

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部